Literature DB >> 26264898

[Opioids for noncancer pain in the elderly].

M Schuler1, N Grießinger2.   

Abstract

BACKGROUND: Opioids are increasingly used in the elderly. Side effects differ compared to other analgesics.
PURPOSE: In this review article, special aspects about using opioids for noncancer pain in older people and in geriatric patients are identified. CURRENT SITUATION: So far randomized controlled trials for the indication of and comparison between various opioids have been performed in middle-aged patients and not exclusively in geriatric patients or elderly (> 75 years). Furthermore, the evidence for multimorbid elderly patients with respect to side effects is also very poor. RECOMMENDATIONS: The indication for opioid therapy should be narrow. The patient and their caregivers must be provided patient information regarding opioid therapy. The principle "start low, go slow" is highly recommended. To reduce the risk of falls, longer acting opioids should be used and short acting opioids should be avoided. Everyday relevant negative effects on cognition are possible in opioid use and have to be observed. As recommended in the recently published German guideline for long-term use of opioids in noncancer pain a critical check after 3 months and in case of dosing over 120 mg morphine equivalents is advisable, especially for older patients. Liver and kidney function and drug interactions have to be taken into consideration like in every age group.

Entities:  

Keywords:  Accidental fall; Adverse effects, drugs; Delirium; Geriatrics; Multimorbidity

Mesh:

Substances:

Year:  2015        PMID: 26264898     DOI: 10.1007/s00482-015-0029-x

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  102 in total

Review 1.  The management of persistent pain in older persons.

Authors: 
Journal:  J Am Geriatr Soc       Date:  2002-06       Impact factor: 5.562

2.  Opioid analgesics and the risk of hip fracture in the elderly: codeine and propoxyphene.

Authors:  R I Shorr; M R Griffin; J R Daugherty; W A Ray
Journal:  J Gerontol       Date:  1992-07

3.  A randomized study to demonstrate noninferiority of once-daily OROS(®) hydromorphone with twice-daily sustained-release oxycodone for moderate to severe chronic noncancer pain.

Authors:  Heinrich Binsfeld; Leszek Szczepanski; Sandra Waechter; Ute Richarz; Rainer Sabatowski
Journal:  Pain Pract       Date:  2010 Sep-Oct       Impact factor: 3.183

4.  [Delirium: an interdisciplinary challenge].

Authors:  T Frühwald; M Weissenberger-Leduc; C Jagsch; K Singler; S Gurlit; W Hofmann; B Böhmdorfer; B Iglseder
Journal:  Z Gerontol Geriatr       Date:  2014-07       Impact factor: 1.281

5.  Influence of age on pain relief from analgesics. A study of postoperative patients.

Authors:  J W Bellville; W H Forrest; E Miller; B W Brown
Journal:  JAMA       Date:  1971-09-27       Impact factor: 56.272

6.  Fracture risk associated with the use of morphine and opiates.

Authors:  P Vestergaard; L Rejnmark; L Mosekilde
Journal:  J Intern Med       Date:  2006-07       Impact factor: 8.989

Review 7.  [Opioids in chronic noncancer pain-are opioids superior to nonopioid analgesics? A systematic review and meta-analysis of efficacy, tolerability and safety in randomized head-to-head comparisons of opioids versus nonopioid analgesics of at least four week's duration].

Authors:  P Welsch; C Sommer; M Schiltenwolf; W Häuser
Journal:  Schmerz       Date:  2015-02       Impact factor: 1.107

Review 8.  [Opioids in chronic osteoarthritis pain. A systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration].

Authors:  R Schaefert; P Welsch; P Klose; C Sommer; F Petzke; W Häuser
Journal:  Schmerz       Date:  2015-02       Impact factor: 1.107

9.  [Use of opioids in the elderly -- pharmacokinetic and pharmacodynamic considerations].

Authors:  E Freye; J V Levy
Journal:  Anasthesiol Intensivmed Notfallmed Schmerzther       Date:  2004-09       Impact factor: 0.698

10.  A randomized, placebo-controlled trial of oxycodone and of gabapentin for acute pain in herpes zoster.

Authors:  Robert H Dworkin; Richard L Barbano; Stephen K Tyring; Robert F Betts; Michael P McDermott; Janet Pennella-Vaughan; Gary J Bennett; Erhan Berber; John W Gnann; Carrie Irvine; Cornelia Kamp; Karl Kieburtz; Mitchell B Max; Kenneth E Schmader
Journal:  Pain       Date:  2009-02-04       Impact factor: 6.961

View more
  6 in total

1.  [Interdisciplinary pain assessment in the hospital setting : Merely a door-opener to multimodal pain therapy?]

Authors:  E Sens; M Mothes-Lasch; J F Lutz
Journal:  Schmerz       Date:  2017-12       Impact factor: 1.107

2.  [Side effects of pain therapy : Sufficient analgesia without unnecessary complications].

Authors:  F Greul; A Zimmer; W Meißner
Journal:  Urologe A       Date:  2017-04       Impact factor: 0.639

Review 3.  [Differential indications of opioids in pain therapy].

Authors:  J Heyn; S C Azad
Journal:  Anaesthesist       Date:  2017-11       Impact factor: 1.041

Review 4.  Opioids in the Elderly Patients with Cognitive Impairment: A Narrative Review.

Authors:  M Rekatsina; A Paladini; O Viswanath; I Urits; D Myrcik; J Pergolizzi; F Breve; G Varrassi
Journal:  Pain Ther       Date:  2022-04-05

5.  Long-term efficacy and safety of oxycodone-naloxone prolonged release in geriatric patients with moderate-to-severe chronic noncancer pain: a 52-week open-label extension phase study.

Authors:  Fabio Guerriero; Anna Roberto; Maria Teresa Greco; Carmelo Sgarlata; Marco Rollone; Oscar Corli
Journal:  Drug Des Devel Ther       Date:  2016-04-19       Impact factor: 4.162

Review 6.  Pharmacotherapy of Pain in the Older Population: The Place of Opioids.

Authors:  Milica Prostran; Katarina Savić Vujović; Sonja Vučković; Branislava Medić; Dragana Srebro; Nevena Divac; Radan Stojanović; Aleksandar Vujović; Lepa Jovanović; Ana Jotić; Nataša Cerovac
Journal:  Front Aging Neurosci       Date:  2016-06-16       Impact factor: 5.750

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.